Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell proliferation. Its structure supports high binding affinity to specific enzyme active sites, making it valuable in developing anticancer agents. Also employed in structure-activity relationship (SAR) studies to optimize drug potency and metabolic stability. Shows potential in the design of central nervous system (CNS) therapeutics due to its ability to cross the blood-brain barrier in preclinical models.